Aurora Cannabis (ACB) Revenue (2017 - 2026)

Aurora Cannabis (ACB) has reported Revenue for 10 consecutive years, with $84.8 million the latest figure, recorded in Q1 2026.

• Quarterly Revenue rose 10.48% year-over-year to $84.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $304.1 million (down 35.0% YoY) and the FY2026 annual result came in at $232.0 million, up 11.62% from the prior year.
• Revenue improved to $84.8 million in Q1 2026 per ACB's latest filing, from $82.9 million in the prior quarter.
• Over the last five years, Revenue for ACB reached as high as $456.0 million in Q2 2023 and fell as low as $39.3 million in Q2 2022.
• A 5-year average of $126.1 million and a median of $76.4 million in 2022 frame the typical range for Revenue.
• Annual changes were most pronounced in 2023 — Revenue soared 1060.07% — and 2024, when it plunged 69.21%.
• Year by year, Revenue stood at $118.1 million in 2022, then plunged by 59.95% to $47.3 million in 2023, then soared by 33.52% to $63.1 million in 2024, then jumped by 31.29% to $82.9 million in 2025, then gained by 2.32% to $84.8 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $84.8 million, $82.9 million, and $65.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.